Specialty and Research interests

Prof. Zhong’s professional skills and expertise include clinical pharmacy and individualized medicine, clinical pharmacology, pharmacogenomics and pharmacoepigenetics, pharmacokinetics and drug metabolism. He focuses his research on the genomic/epigenetic mechanism of individual differences in efficacy and toxicity of drug therapy for patients with coronary heart disease (CHD).

Education

Postdoctoral training, Pharmacogenomics, University of Pittsburgh

Doctor, Pharmacology, Sun Yat-sen University

Bachelor, Clinical pharmacy, Sichuan University

Professional memberships

• Committee Chairman, Therapeutic Drug Monitoring of Pharmacological Society of Guangdong Province.
• Member of Standing Committee and Secretary-General of Pharmacoepigenetic Committee, Chinese Pharmacological Society.
• Member of Standing Committee, Pharmacogenomic Committee of Chinese Pharmacological Society.
• Member of Standing Committee, Therapeutic Drug Monitoring Committee of Chinese Pharmacological Society.
• Member of Clinical Pharmacology Committee, Chinese Pharmacological Society.
• Member of CCCP, Chinese College of Cardiovascular Physicians.
• Member of Standing Committee,Pharmacological Society of Guangdong Province.Vice Chairman, drug metabolism of Pharmacological Society of Guangdong

Awards and honors

Distinguished Young Medical Scientists of Guangdong

First-class Hospital Pharmacy Science and Technology Award of Guangdong Pharmaceutical Society.

Third-class Science and Technology Award of Chinese Pharmaceutical Association.

Research

Prof. Zhong received more than 15 funds, including the National Key Research and Development Program (No. 2017YFC0909301), National Nature Science Foundation of China (No. 81872934, 81673514, 81373486, 81072701), key research and development program of Guangdong Province (2019B020229003), Science and Technology Development Projects of Guangdong Province (No. 2016B090918114). Prof. Zhong has published more than 50 SCI papers, including papers in Nature, Clin Pharmacol Ther, Nature Communications, J Clin Oncol, Clin Pharmacokinet, and JLR.